Quintiles, London Genetics Ink PGx Services Pact | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quintiles and London Genetics have struck a partnership to provide biomarker and pharmacogenomics consulting and services to biopharmaceutical firms, Research Triangle Park, NC-based Quintiles said today.

The two companies will collaborate to provide pharmacogenetic solutions, including novel biomarker and assay development services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.